Amedisys Company Profile (NASDAQ:AMED)

About Amedisys (NASDAQ:AMED)

Amedisys logoAmedisys, Inc. is a healthcare services company. The Company's segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia. The Company's Home Health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The Hospice segment provides support for those who are dealing with a terminal illness. The Personal care segment provides patients with assistance with the essential activities of daily living.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Home Healthcare Services
  • Sub-Industry: Health Care Services
  • Symbol: NASDAQ:AMED
  • CUSIP: 02343610
  • Web: www.amedisys.com
Capitalization:
  • Market Cap: $1.67 billion
  • Outstanding Shares: 33,862,000
Average Prices:
  • 50 Day Moving Avg: $51.89
  • 200 Day Moving Avg: $55.18
  • 52 Week Range: $34.58 - $65.91
P/E:
  • Trailing P/E Ratio: 42.09
  • Foreward P/E Ratio: 20.27
  • P/E Growth: 1.14
Sales & Book Value:
  • Annual Revenue: $1.45 billion
  • Price / Sales: 1.15
  • Book Value: $14.54 per share
  • Price / Book: 3.39
Profitability:
  • EBITDA: $105.65 million
  • Net Margins: 2.70%
  • Return on Equity: 13.71%
  • Return on Assets: 8.56%
Debt:
  • Debt-to-Equity Ratio: 0.17%
  • Current Ratio: 1.21%
  • Quick Ratio: 1.21%
Misc:
  • Average Volume: 414,225 shs.
  • Beta: 0.87
  • Short Ratio: 4.52
 

Frequently Asked Questions for Amedisys (NASDAQ:AMED)

What is Amedisys' stock symbol?

Amedisys trades on the NASDAQ under the ticker symbol "AMED."

How were Amedisys' earnings last quarter?

Amedisys Inc (NASDAQ:AMED) issued its quarterly earnings data on Wednesday, July, 26th. The company reported $0.62 EPS for the quarter, beating the consensus estimate of $0.50 by $0.12. The firm earned $378.80 million during the quarter, compared to analyst estimates of $380.80 million. Amedisys had a return on equity of 13.71% and a net margin of 2.70%. The business's revenue for the quarter was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.42 EPS. View Amedisys' Earnings History.

When will Amedisys make its next earnings announcement?

Amedisys is scheduled to release their next quarterly earnings announcement on Thursday, November, 2nd 2017. View Earnings Estimates for Amedisys.

Where is Amedisys' stock going? Where will Amedisys' stock price be in 2017?

10 equities research analysts have issued 1-year target prices for Amedisys' shares. Their forecasts range from $50.00 to $60.00. On average, they expect Amedisys' stock price to reach $56.20 in the next twelve months. View Analyst Ratings for Amedisys.

What are analysts saying about Amedisys stock?

Here are some recent quotes from research analysts about Amedisys stock:

  • 1. Jefferies Group LLC analysts commented, "We are excited about AMED's 2017 outlook given our view that the company's Q4 performance (margin-driven earnings beat) foreshadows accelerating realization of benefits from its recently-completed IT rollout that should translate into strong earnings power and stock upside. Additionally, AMED's strong balance sheet and robust FCF, coupled with its $100MM EBITDA deal pipeline, should translate to an active year for accretive, upside-driving acquisitions." (3/1/2017)
  • 2. Mizuho analysts commented, "Bumps? What bumps? AMED produced 4Q16 SS home health admit growth, nice margin gains and 15% upside to our adj. EBITDA estimate. For '17E, AMED seems poised to realize $40+mm in actual cost savings, admit growth in HH and continued strong growth in hospice, enough to more than offset a $17 mm hit from HH pricing to achieve EBITDA growth of 28%+ in '17E. But the not-so-cheap stock price "knows" that even though we have no guidance yet and a brand new management team. So we reset our PT at $50 to reflect market re-rating, strong results and the prospect of the real, new AMED emerging in 2017." (3/1/2017)

Who are some of Amedisys' key competitors?

Who are Amedisys' key executives?

Amedisys' management team includes the folowing people:

  • Paul B. Kusserow, President, Chief Executive Officer, Director
  • Gary D. Willis, Chief Financial Officer
  • Christopher T. Gerard, Chief Operating Officer
  • Lawrence R. Pernosky, Chief Human Resource Officer
  • Scott G. Ginn, Chief Accounting Officer
  • Michael Paul North, Chief Information Officer
  • David B. Pearce, Chief Compliance Officer
  • David L. Kemmerly, General Counsel
  • Stephen E. Seim, Chief Strategy Officer
  • Susan Sender, Chief Clinical Operations Officer

How do I buy Amedisys stock?

Shares of Amedisys can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Amedisys' stock price today?

One share of Amedisys stock can currently be purchased for approximately $49.25.


MarketBeat Community Rating for Amedisys (NASDAQ AMED)
Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  169 (Vote Outperform)
Underperform Votes:  338 (Vote Underperform)
Total Votes:  507
MarketBeat's community ratings are surveys of what our community members think about Amedisys and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Amedisys (NASDAQ:AMED) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 6 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $56.20 (14.11% upside)
Consensus Price Target History for Amedisys (NASDAQ:AMED)
Price Target History for Amedisys (NASDAQ:AMED)
Analysts' Ratings History for Amedisys (NASDAQ:AMED)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/12/2017Jefferies Group LLCReiterated RatingBuy$60.00N/AView Rating Details
10/9/2017SunTrust Banks, Inc.Reiterated RatingBuy$60.00N/AView Rating Details
10/4/2017Robert W. BairdReiterated RatingHold$50.00LowView Rating Details
9/15/2017Oppenheimer Holdings, Inc.Reiterated RatingBuy$60.00LowView Rating Details
8/21/2017Bank of America CorporationInitiated CoverageNeutral -> Neutral$55.00LowView Rating Details
7/26/2017MizuhoDowngradeBuy -> Neutral$50.00HighView Rating Details
6/5/2017Royal Bank Of CanadaReiterated RatingHold$56.00LowView Rating Details
5/4/2017StephensBoost Price TargetEqual Weight$50.00 -> $54.00LowView Rating Details
5/3/2017Benchmark Co.Reiterated RatingHold -> Hold$50.00 -> $57.00HighView Rating Details
1/17/2017Craig HallumSet Price TargetBuy$60.00N/AView Rating Details
9/11/2016Wells Fargo & CompanyReiterated RatingBuyN/AView Rating Details
1/11/2016Raymond James Financial, Inc.UpgradeUnderperform -> Market PerformN/AView Rating Details
11/6/2015Piper Jaffray CompaniesReiterated RatingNeutral$42.00 -> $45.00N/AView Rating Details
(Data available from 10/18/2015 forward)

Earnings

Earnings History for Amedisys (NASDAQ:AMED)
Earnings by Quarter for Amedisys (NASDAQ:AMED)
Earnings History by Quarter for Amedisys (NASDAQ AMED)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2017$0.53N/AView Earnings Details
7/26/2017Q2 2017$0.50$0.62$380.80 million$378.80 millionViewN/AView Earnings Details
5/2/2017Q1 2017$0.41$0.47$370.03 million$370.46 millionViewListenView Earnings Details
2/28/2017Q4 2016$0.39$0.44$368.14 million$366.30 millionViewN/AView Earnings Details
11/3/2016Q3$0.36$0.36$361.08 million$361.60 millionViewListenView Earnings Details
8/2/2016Q2$0.42$0.42$353.07 million$360.00 millionViewListenView Earnings Details
5/3/2016Q1$0.33$0.33$337.07 million$348.80 millionViewListenView Earnings Details
3/8/2016Q415$0.35$0.40$322.67 million$338.37 millionViewListenView Earnings Details
11/5/2015Q315$0.34$0.34$312.22 million$326.50 millionViewListenView Earnings Details
7/29/2015Q215$0.33$0.43$307.11 million$314.20 millionViewListenView Earnings Details
4/29/2015Q115$0.20$0.30$300.17 million$301.60 millionViewListenView Earnings Details
3/4/2015Q414$0.27$0.27$301.62 million$300.50 millionViewListenView Earnings Details
10/29/2014Q314$0.17$0.28$299.26 million$300.30 millionViewListenView Earnings Details
7/30/2014Q214$0.17$0.25$298.90 million$305.00 millionViewListenView Earnings Details
5/8/2014Q114($0.06)($0.07)$301.89 million$298.74 millionViewListenView Earnings Details
3/12/2014Q413($0.01)($0.05)$295.02 million$303.50 millionViewListenView Earnings Details
11/12/2013Q313$0.13$0.06$314.30 million$301.64 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.10$0.06$328.02 million$313.10 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.18$0.13$361.41 million$339.20 millionViewListenView Earnings Details
3/12/2013Q4 2012$0.22$0.24$373.31 million$632.90 millionViewListenView Earnings Details
11/6/2012Q312$0.27$0.33$379.97 million$375.62 millionViewN/AView Earnings Details
8/7/2012$0.24$0.27ViewN/AView Earnings Details
5/8/2012$0.22$0.22ViewN/AView Earnings Details
2/28/2012$0.29$0.25ViewN/AView Earnings Details
11/1/2011$0.50$0.36ViewN/AView Earnings Details
8/2/2011$0.69$0.75ViewN/AView Earnings Details
4/26/2011$0.66$0.53ViewN/AView Earnings Details
2/22/2011$0.91$0.77ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Amedisys (NASDAQ:AMED)
2017 EPS Consensus Estimate: $2.03
2018 EPS Consensus Estimate: $2.52
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.40$0.42$0.41
Q2 20173$0.48$0.55$0.51
Q3 20173$0.53$0.54$0.53
Q4 20173$0.57$0.60$0.58
Q1 20182$0.54$0.58$0.56
Q2 20182$0.62$0.63$0.63
Q3 20182$0.64$0.66$0.65
Q4 20182$0.67$0.70$0.69
Q1 20191$0.68$0.68$0.68
Q2 20191$0.71$0.71$0.71
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Amedisys (NASDAQ:AMED)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Amedisys (NASDAQ:AMED)
Insider Ownership Percentage: 2.00%
Institutional Ownership Percentage: 96.55%
Insider Trades by Quarter for Amedisys (NASDAQ:AMED)
Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)
Insider Trades by Quarter for Amedisys (NASDAQ:AMED)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/8/2017David B PearceInsiderSell1,000$50.00$50,000.00View SEC Filing  
8/3/2017Bruce D PerkinsDirectorBuy2,000$46.60$93,200.00View SEC Filing  
5/25/2017Bruce D PerkinsDirectorBuy500$59.69$29,845.00View SEC Filing  
5/12/2017Jake L NettervilleDirectorSell10,000$60.00$600,000.00View SEC Filing  
5/10/2017Lawrence R PernoskyInsiderSell11,500$58.97$678,155.00View SEC Filing  
5/9/2017Lawrence R PernoskyInsiderSell11,500$58.78$675,970.00View SEC Filing  
5/8/2017Scott G GinnInsiderSell23,828$58.62$1,396,797.36View SEC Filing  
5/13/2016Bruce D PerkinsDirectorBuy1,000$50.21$50,210.00View SEC Filing  
5/11/2016Scott G GinnInsiderSell6,000$51.62$309,720.00View SEC Filing  
11/2/2015North Tide Capital, LlcMajor ShareholderSell277,720$39.79$11,050,478.80View SEC Filing  
10/28/2015North Tide Capital, LlcMajor ShareholderSell191,400$39.86$7,629,204.00View SEC Filing  
10/26/2015North Tide Capital, LlcMajor ShareholderSell56,400$39.32$2,217,648.00View SEC Filing  
8/18/2015Donald A WashburnDirectorSell20,000$45.51$910,200.00View SEC Filing  
3/13/2015Jeffrey D JeterInsiderSell11,264$27.02$304,353.28View SEC Filing  
3/13/2015Peter RicchiutiDirectorSell2,003$27.25$54,581.75View SEC Filing  
8/5/2014Jeffrey D JeterInsiderSell2,500$21.80$54,500.00View SEC Filing  
5/8/2014North Tide Capital, Llcmajor shareholderBuy500,000$13.90$6,950,000.00View SEC Filing  
5/1/2014North Tide Capital, Llcmajor shareholderBuy150,000$13.54$2,031,000.00View SEC Filing  
11/21/2013Kkr Asset Management Llcmajor shareholderBuy425,515$14.48$6,161,457.20View SEC Filing  
11/15/2013David BuceyGeneral CounselSell8,290$13.95$115,645.50View SEC Filing  
11/14/2013Kkr Asset Management Llcmajor shareholderBuy946,500$13.89$13,146,885.00View SEC Filing  
10/30/2013Kkr Asset Management LlcMajor ShareholderBuy29,615$15.94$472,063.10View SEC Filing  
10/22/2013Kkr Asset Management LlcMajor ShareholderBuy186,013$17.55$3,264,528.15View SEC Filing  
10/18/2013Kkr Asset Management LlcMajor ShareholderBuy12,652$17.95$227,103.40View SEC Filing  
7/3/2013Linda J HallDirectorSell1,721$10.65$18,328.65View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Amedisys (NASDAQ:AMED)
Latest Headlines for Amedisys (NASDAQ:AMED)
Source:
DateHeadline
americanbankingnews.com logoAmedisys Inc (AMED) Given "Buy" Rating at Jefferies Group LLC
www.americanbankingnews.com - October 15 at 5:16 PM
nasdaq.com logoAmedisys Unveils Program for Its 60,000 COPD Patients
www.nasdaq.com - October 12 at 4:38 PM
finance.yahoo.com logoJax-based health care technology company lands big client
finance.yahoo.com - October 11 at 5:22 PM
rttnews.com logoAmedisys Inc. (AMED) Fell To A 6-Week Low
www.rttnews.com - October 10 at 5:11 PM
finance.yahoo.com logoFeatured Company News - Amedisys Announces Appointment of New CFO
finance.yahoo.com - October 10 at 5:11 PM
finance.yahoo.com logoAmedisys, Inc. breached its 50 day moving average in a Bearish Manner : AMED-US : October 10, 2017
finance.yahoo.com - October 10 at 5:11 PM
americanbankingnews.com logoSunTrust Banks, Inc. Reiterates "Buy" Rating for Amedisys Inc (AMED)
www.americanbankingnews.com - October 9 at 3:50 PM
americanbankingnews.com logo$388.54 Million in Sales Expected for Amedisys Inc (AMED) This Quarter
www.americanbankingnews.com - October 8 at 3:20 AM
seekingalpha.com logoAmedisys promotes Ginn to chief financial officer
seekingalpha.com - October 6 at 7:26 PM
feeds.benzinga.com logoScott Ginn Promoted to Chief Financial Officer at Amedisys
feeds.benzinga.com - October 6 at 6:59 PM
finance.yahoo.com logoAmedisys' Arm Buys Intercity Home Care, Boosts U.S. Base
finance.yahoo.com - October 3 at 3:35 PM
finance.yahoo.com logoAmedisys' Arm Buys Intercity Home Care, Boosts U.S. Base
finance.yahoo.com - October 3 at 3:35 PM
feeds.benzinga.com logoAmedisys Closes on Acquisition of Intercity Home Care
feeds.benzinga.com - October 2 at 7:49 AM
americanbankingnews.com logoAmedisys Inc (AMED) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - October 1 at 11:06 AM
msn.com logoHere's Why You Should Invest in Orthofix International Now
www.msn.com - September 27 at 8:06 PM
prnewswire.com logoBernstein Litowitz Berger & Grossmann LLP and Wolf Popper LLP Announce a Proposed Settlement of Amedisys, Inc. Securities Litigation
www.prnewswire.com - September 27 at 8:06 PM
nasdaq.com logoSeventy-One Amedisys Care Centers Receive SHPBest Awards
www.nasdaq.com - September 23 at 12:34 AM
finance.yahoo.com logoMedtronic Advances in Pain Therapy With U.S. Intellis Launch
finance.yahoo.com - September 22 at 2:30 PM
finance.yahoo.com logoNeogen (NEOG) Earnings and Revenues Beat Estimates in Q1
finance.yahoo.com - September 20 at 3:51 PM
finance.yahoo.com logoBecton, Dickinson Ultra-Fine Needle to Improve Diabetic Care
finance.yahoo.com - September 20 at 3:51 PM
finance.yahoo.com logoBoston Scientific MultiSENSE Study on HeartLogic Positive
finance.yahoo.com - September 20 at 3:50 PM
finance.yahoo.com logoRepublicans Take Last Shot at Obamacare: 5 MedTech Stocks to Buy
finance.yahoo.com - September 20 at 3:50 PM
nasdaq.com logoAMED Makes Notable Cross Below Critical Moving Average
www.nasdaq.com - September 19 at 8:50 PM
finance.yahoo.com logoBruker (BRKR) Strong on Product Launches Amid Currency Woes
finance.yahoo.com - September 19 at 3:49 PM
finance.yahoo.com logoWill Hurricanes Choke Cardiovascular (CSII) Q1 Performance?
finance.yahoo.com - September 19 at 3:49 PM
finance.yahoo.com logoWhy the Earnings Streak Will Continue for Amedisys (AMED)
finance.yahoo.com - September 18 at 4:12 PM
finance.yahoo.com logo5 MedTech Stocks to Pick for Stellar Returns
finance.yahoo.com - September 18 at 4:12 PM
americanbankingnews.com logoQ1 2019 Earnings Forecast for Amedisys Inc Issued By SunTrust Banks (AMED)
www.americanbankingnews.com - September 18 at 8:46 AM
finance.yahoo.com logoAmedisys, Inc. – Value Analysis (NASDAQ:AMED) : September 15, 2017
finance.yahoo.com - September 15 at 9:11 PM
americanbankingnews.com logoAmedisys Inc (AMED) Receives Buy Rating from Oppenheimer Holdings, Inc.
www.americanbankingnews.com - September 15 at 4:52 PM
finance.yahoo.com logoAmedisys Rides High on Strong Prospects Amid Margin Woes
finance.yahoo.com - September 14 at 4:21 PM
finance.yahoo.com logoFresenius Medical Opens Manufacturing Plant in Malaysia
finance.yahoo.com - September 14 at 4:21 PM
finance.yahoo.com logoAmedisys, Inc. breached its 50 day moving average in a Bearish Manner : AMED-US : September 14, 2017
finance.yahoo.com - September 14 at 4:21 PM
finance.yahoo.com logoInovalon Holdings' ONE Platform Chosen by UnitedHealthcare
finance.yahoo.com - September 14 at 4:21 PM
finance.yahoo.com logoMedtronic Launches StealthStation Technology, Expands in ENT
finance.yahoo.com - September 13 at 4:58 PM
finance.yahoo.com logoIDEXX Laboratories Rides High on Strong CAG, Global Growth
finance.yahoo.com - September 13 at 4:57 PM
finance.yahoo.com logo5 Discounted MedTech Stocks for a Healthy Portfolio
finance.yahoo.com - September 12 at 4:02 PM
finance.yahoo.com logoTop Ranked Growth Stocks to Buy for September 11th
finance.yahoo.com - September 11 at 4:45 PM
wsj.com logoThe Corporate Hurricane: Houston CEOs Race to Mend a Battered Workforce
www.wsj.com - September 8 at 4:14 PM
msn.com logoCorporate Hurricane: Houston CEOs Race to Mend a Battered Workforce
www.msn.com - September 7 at 3:50 PM
americanbankingnews.com logoAmedisys Inc (AMED) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - September 6 at 11:01 AM
finance.yahoo.com logoAmedisys to Buy Intercity Home Care, Boosts Personal Care Arm
finance.yahoo.com - September 1 at 4:22 PM
reuters.com logoBRIEF-Amedisys announces definitive agreement to acquire Intercity Home Care
www.reuters.com - August 31 at 8:48 PM
nasdaq.com logoAmedisys Unit To Acquire Intercity Home Care - Quick Facts
www.nasdaq.com - August 31 at 8:48 PM
streetinsider.com logoAmedisys (AMED) to Acquire Intercity Home Care
www.streetinsider.com - August 31 at 8:48 PM
finance.yahoo.com logo3 Excellent Value Picks as Political Chaos Grips MedTech
finance.yahoo.com - August 31 at 8:48 PM
finance.yahoo.com logoAmedisys Announces Definitive Agreement to Acquire Intercity Home Care
finance.yahoo.com - August 31 at 3:43 PM
seekingalpha.com logoAmedisys buys MA-based Intercity Home Care
seekingalpha.com - August 31 at 8:44 AM
finance.yahoo.com logoAmedisys (AMED) Up 3.6% Since Earnings Report: Can It Continue?
finance.yahoo.com - August 29 at 4:06 PM
finance.yahoo.com logoHere's Why Chemed (CHE) is a Suitable Growth Pick for Now
finance.yahoo.com - August 28 at 3:52 PM

Social

Chart

Amedisys (AMED) Chart for Wednesday, October, 18, 2017

This page was last updated on 10/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.